Introduction Prime Medicine (NASDAQ:PRME) is a biotech firm pioneering the use of Prime Editors, revolutionary genetic therapies that offer precise, efficient and broad gene...
The Russian Central Bank could begin “real-world” tests on the digital ruble next month after parliament approved a key piece of CBDC legislation. Per...